Prakash Ambady

9PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersCancer geneticsTe mātai tahumaero o te Māori (Māori epidemiology)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 01, 2026
Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial.

|Mar 31, 2025
A pilot survey into the landscape of neuro-oncology care in the community.

Christine Lu-Emerson, Sajeel Chowdhary, Rupesh Kotecha

|Dec 11, 2023
Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes.

Jared Stoller, Cymon N Kersch, Leslie L Muldoon

|Apr 19, 2023
Mismatch repair-deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of Lynch syndrome.

Hao Tan, Caleb Nerison, Cooper Stateler

|Jul 27, 2022
Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.

Kutluay Uluc, Prakash Ambady, Matthew K McIntyre

|Dec 16, 2020
The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series.

Stephen G Bowden, Daniel N Munger, Jaclyn Thiessen

Pageof 2

Frequent Collaborators

4 joint publications

Rongwei Fu

4 joint publications

Edward A Neuwelt

4 joint publications

Ramon F Barajas

3 joint publications

Aclan Dogan